National Research (NASDAQ:NRC) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next?

National Research Corporation (NASDAQ:NRC) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $18.13 and traded as high as $22.51. National Research shares last traded at $21.98, with a volume of 96,977 shares trading hands.

Wall Street Analyst Weigh In

NRC has been the subject of a number of analyst reports. Citizens Jmp assumed coverage on National Research in a research note on Monday, June 22nd. They set a “market outperform” rating and a $23.00 price target for the company. Weiss Ratings raised National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, National Research currently has an average rating of “Moderate Buy” and a consensus target price of $23.00.

National Research Trading Up 0.7%

The company has a debt-to-equity ratio of 5.48, a quick ratio of 0.52 and a current ratio of 0.52. The firm has a market cap of $500.05 million, a P/E ratio of 56.36 and a beta of 0.35. The firm has a 50 day simple moving average of $19.89 and a 200 day simple moving average of $18.13.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 EPS for the quarter. The firm had revenue of $34.80 million during the quarter. National Research had a net margin of 6.52% and a return on equity of 122.73%.

Hedge Funds Weigh In On National Research

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Heartland Advisors Inc. grew its position in National Research by 374.3% in the first quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock worth $4,027,000 after acquiring an additional 187,147 shares in the last quarter. AQR Capital Management LLC increased its stake in National Research by 86.2% in the second quarter. AQR Capital Management LLC now owns 201,396 shares of the company’s stock valued at $3,383,000 after acquiring an additional 93,262 shares during the last quarter. Fifth Third Bancorp purchased a new stake in National Research during the first quarter valued at about $1,531,000. Jane Street Group LLC raised its position in National Research by 394.2% during the first quarter. Jane Street Group LLC now owns 52,411 shares of the company’s stock valued at $671,000 after purchasing an additional 41,806 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its stake in National Research by 180.8% during the third quarter. Arrowstreet Capital Limited Partnership now owns 49,076 shares of the company’s stock worth $627,000 after purchasing an additional 31,599 shares during the last quarter. Hedge funds and other institutional investors own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.